Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Sep 23 · below the Ichimoku cloud · RSI 21 (oversold) · MACD below its signal · 1% above its 52-week low
None of the 29 investors followed here reported a position in ACRE in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a ACRE trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Apr 28, 2026 | Browning WilliamDirector | Stock Award(Grant) at price 0.00 per share. | 18.9K | — |
| Apr 28, 2026 | Blakely CarolineDirector | Stock Award(Grant) at price 0.00 per share. | 18.9K | — |
| Apr 28, 2026 | April Rand ScottDirector | Stock Award(Grant) at price 0.00 per share. | 18.9K | — |
| Apr 28, 2026 | Moriarty Edmond N IiiDirector | Stock Award(Grant) at price 0.00 per share. | 18.9K | — |
| Apr 28, 2026 | Parekh Rebecca JaisaliDirector | Stock Award(Grant) at price 0.00 per share. | 18.9K | — |
| Apr 28, 2026 | Skinner James EDirector | Stock Award(Grant) at price 0.00 per share. | 18.9K | — |
| Jan 13, 2026 | Feingold AntonGeneral Counsel | Sale at price 4.93 per share. | 7.6K | $37.48K |
| Jan 13, 2026 | Donohoe Bryan PatrickChief Executive Officer | Sale at price 4.93 per share. | 21.8K | $107.23K |
| Jan 13, 2026 | Gonzales Jeffrey MichaelChief Financial Officer | Sale at price 4.93 per share. | 6.2K | $30.64K |
| Dec 10, 2025 | Yoon Tae SikChief Operating Officer | Stock Award(Grant) at price 0.00 per share. | 37.4K | — |
| Dec 10, 2025 | Feingold AntonGeneral Counsel | Stock Award(Grant) at price 0.00 per share. | 22K | — |
| Dec 10, 2025 | Donohoe Bryan PatrickChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 49.5K | — |
| Dec 10, 2025 | Gonzales Jeffrey MichaelChief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 44K | — |
| Apr 28, 2025 | Browning WilliamDirector | Stock Award(Grant) at price 0.00 per share. | 24.7K | — |
| Apr 28, 2025 | Blakely CarolineDirector | Stock Award(Grant) at price 0.00 per share. | 24.7K | — |
| Apr 28, 2025 | April Rand ScottDirector | Stock Award(Grant) at price 0.00 per share. | 24.7K | — |
| Apr 28, 2025 | Moriarty Edmond N IiiDirector | Stock Award(Grant) at price 0.00 per share. | 24.7K | — |
| Apr 28, 2025 | Parekh Rebecca JaisaliDirector | Stock Award(Grant) at price 0.00 per share. | 24.7K | — |
| Apr 28, 2025 | Skinner James EDirector | Stock Award(Grant) at price 0.00 per share. | 24.7K | — |
| Jan 30, 2025 | Feingold AntonGeneral Counsel | Sale at price 5.68 per share. | 7.6K | $43.26K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 9.0 | -3.6 | -4.4 | 9.0 | -5.5 | -8.9 | -5.3 | 7.3 | -16.0 | -8.9 | −26.8% | ||
| 2025 | -3.9 | -13.6 | -5.3 | -12.1 | 13.3 | 3.5 | -6.3 | 5.6 | -4.4 | -1.1 | 18.8 | -9.8 | −18.8% |
| 2024 | -8.2 | -20.7 | -1.2 | -8.9 | 2.5 | -4.5 | 16.2 | -8.7 | -0.8 | -9.3 | 13.7 | -18.4 | −43.1% |
| 2023 | 19.3 | -7.9 | -19.6 | -5.3 | 6.7 | 10.4 | 5.0 | -2.9 | -8.0 | -3.7 | 9.6 | 3.1 | +0.7% |
| 2022 | 1.0 | -0.3 | 5.9 | -2.9 | -2.5 | -16.8 | 12.0 | -3.7 | -20.8 | 18.1 | 1.0 | -17.4 | −29.2% |
| 2021 | -5.0 | 22.0 | -0.7 | 7.6 | 2.8 | -3.2 | 2.7 | 4.6 | -4.4 | 3.6 | -5.8 | -1.2 | +22.1% |
| 2020 | 3.2 | -6.6 | -54.2 | 10.9 | -3.9 | 22.4 | 0.1 | 9.1 | -8.2 | 1.9 | 19.7 | 6.9 | −24.8% |
| 2019 | 10.4 | 6.0 | -0.5 | 0.1 | -3.4 | 1.2 | 2.1 | -1.2 | 1.6 | 1.8 | 0.9 | 1.3 | +21.5% |
| 2018 | -1.8 | -2.8 | 0.2 | -1.0 | 13.0 | -0.1 | 2.2 | 3.5 | -4.4 | 3.6 | -1.3 | -8.7 | +1.1% |
| 2017 | -1.8 | 0.3 | -1.0 | 3.4 | -4.3 | -1.1 | -2.2 | 3.0 | 0.9 | -2.5 | 3.9 | -4.3 | −6.0% |
| 2016 | -6.8 | -8.5 | 12.3 | 9.6 | -0.2 | 2.6 | 3.3 | -1.0 | 0.2 | 4.1 | 3.1 | 1.5 | +20.0% |
| 2015 | 4.8 | -0.2 | -7.9 | 2.7 | 2.6 | -2.2 | 9.3 | 0.6 | -4.2 | 2.9 | 4.3 | -11.1 | −0.3% |
| 2014 | 1.8 | 2.0 | -1.3 | -4.8 | -1.8 | -1.0 | -1.5 | 3.0 | -7.1 | 4.0 | -1.7 | -3.9 | −12.4% |
| 2013 | 5.4 | -1.6 | -0.6 | -0.5 | -3.7 | -21.0 | 2.6 | -2.8 | -2.7 | 0.0 | 5.6 | -0.2 | −20.2% |
| 2012 | -8.3 | 6.0 | -4.2 | 0.6 | 1.3 | -1.1 | -2.5 | -0.2 | −8.7% |
Ares Commercial Real Estate Corporation, a specialty finance company, engages in the originating and investing in commercial real estate (CRE) loans and related investments in the United States. The company provides loan opportunities for the owners, operators, and sponsors of CRE properties. Its investments includes senior mortgage loans, subordinate debt, preferred equity products, mezzanine loans, and other CRE investments, such as commercial mortgage-backed securities. It has elected and qualified to be taxed as a real estate investment trust for the United States federal income tax purposes under the Internal Revenue Code of 1986. Ares Commercial Real Estate Corporation was incorporated in 2011 and is based in New York, New York.
Buy / hold / sell counts